Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis.

Rollinson S, Young K, Bennion-Callister J, Pickering-Brown SM.

Eur J Neurosci. 2016 Jun 16. doi: 10.1111/ejn.13297. [Epub ahead of print]

PMID:
27307215
2.

ABCA7 p.G215S as potential protective factor for Alzheimer's disease.

Sassi C, Nalls MA, Ridge PG, Gibbs JR, Ding J, Lupton MK, Troakes C, Lunnon K, Al-Sarraj S, Brown KS, Medway C, Clement N, Lord J, Turton J, Bras J, Almeida MR; ARUK Consortium, Holstege H, Louwersheimer E, van der Flier WM, Scheltens P, Van Swieten JC, Santana I, Oliveira C, Morgan K, Powell JF, Kauwe JS, Cruchaga C, Goate AM, Singleton AB, Guerreiro R, Hardy J.

Neurobiol Aging. 2016 Apr 20. pii: S0197-4580(16)30031-8. doi: 10.1016/j.neurobiolaging.2016.04.004. [Epub ahead of print]

3.

Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.

Behrouzi R, Liu X, Wu D, Robinson AC, Tanaguchi-Watanabe S, Rollinson S, Shi J, Tian J, Hamdalla HH, Ealing J, Richardson A, Jones M, Pickering-Brown S, Davidson YS, Strong MJ, Hasegawa M, Snowden JS, Mann DM.

Acta Neuropathol Commun. 2016 Mar 31;4:33. doi: 10.1186/s40478-016-0301-z.

4.

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.

Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, Knopman DS, Rabinovici GD, Miller BL, González AS, Gil-Néciga E, Snowden JS, Harris J, Pickering-Brown SM, Louwersheimer E, van der Flier WM, Scheltens P, Pijnenburg YA, Galasko D, Sarazin M, Dubois B, Magnin E, Galimberti D, Scarpini E, Cappa SF, Hodges JR, Halliday GM, Bartley L, Carrillo MC, Bras JT, Hardy J, Rossor MN, Collinge J, Fox NC, Mead S.

Alzheimers Dement. 2016 Aug;12(8):862-71. doi: 10.1016/j.jalz.2016.01.010. Epub 2016 Mar 15.

5.

Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease.

Barber IS, García-Cárdenas JM, Sakdapanichkul C, Deacon C, Zapata Erazo G, Guerreiro R, Bras J, Hernandez D, Singleton A, Guetta-Baranes T, Braae A, Clement N, Patel T, Brookes K, Medway C, Chappell S, Mann DM; ARUK Consortium, Morgan K.

Neurobiol Aging. 2016 Mar;39:220.e1-7. doi: 10.1016/j.neurobiolaging.2015.12.011. Epub 2015 Dec 29.

PMID:
26803359
6.

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.

Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK; International Parkinson's Disease Genomics Consortium, Dickson D, Hardy J, Singleton A, Bras J.

Neurobiol Aging. 2016 Feb;38:214.e7-10. doi: 10.1016/j.neurobiolaging.2015.10.028. Epub 2015 Nov 2.

7.

Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins.

Davidson Y, Robinson AC, Liu X, Wu D, Troakes C, Rollinson S, Masuda-Suzukake M, Suzuki G, Nonaka T, Shi J, Tian J, Hamdalla H, Ealing J, Richardson A, Jones M, Pickering-Brown S, Snowden JS, Hasegawa M, Mann DM.

Neuropathol Appl Neurobiol. 2016 Apr;42(3):242-54. doi: 10.1111/nan.12292. Epub 2015 Dec 7.

8.

Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.

Snowden JS, Adams J, Harris J, Thompson JC, Rollinson S, Richardson A, Jones M, Neary D, Mann DM, Pickering-Brown S.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):497-505. doi: 10.3109/21678421.2015.1074700. Epub 2015 Oct 16.

PMID:
26473392
9.

Left hand dystonia as a recurring feature of a family carrying C9ORF72 mutation.

Luzzi S, Girelli F, Fiori C, Ranaldi V, Baldinelli S, Cameriere V, Silvestrini M, Provinciali L, Rollinson S, Pickering-Brown S, Mann D, Snowden JS.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):793-5. doi: 10.1136/jnnp-2015-311311. Epub 2015 Jul 17. No abstract available.

PMID:
26187722
10.

Is SIGMAR1 a confirmed FTD/MND gene?

Pickering-Brown S, Hardy J.

Brain. 2015 Nov;138(Pt 11):e393. doi: 10.1093/brain/awv173. Epub 2015 Jun 18. No abstract available.

PMID:
26088964
11.

Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy.

Cooper-Knock J, Higginbottom A, Stopford MJ, Highley JR, Ince PG, Wharton SB, Pickering-Brown S, Kirby J, Hautbergue GM, Shaw PJ.

Acta Neuropathol. 2015 Jul;130(1):63-75. doi: 10.1007/s00401-015-1429-9. Epub 2015 May 6.

12.

Psychosis associated with expansions in the C9orf72 gene: the influence of a 10 base pair gene deletion.

Snowden JS, Harris J, Adams J, Thompson JC, Richardson AM, Jones MS, Neary D, Davidson YS, Robinson AC, Rollinson S, Pickering-Brown S, Mann DM.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):562-3. doi: 10.1136/jnnp-2015-310441. Epub 2015 Apr 2. No abstract available.

PMID:
25835037
13.

A novel Alzheimer disease locus located near the gene encoding tau protein.

Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, Beecham GW, Smith AV, Chouraki V, Hamilton-Nelson KL, Ikram MA, Fievet N, Denning N, Martin ER, Schmidt H, Kamatani Y, Dunstan ML, Valladares O, Laza AR, Zelenika D, Ramirez A, Foroud TM, Choi SH, Boland A, Becker T, Kukull WA, van der Lee SJ, Pasquier F, Cruchaga C, Beekly D, Fitzpatrick AL, Hanon O, Gill M, Barber R, Gudnason V, Campion D, Love S, Bennett DA, Amin N, Berr C, Tsolaki M, Buxbaum JD, Lopez OL, Deramecourt V, Fox NC, Cantwell LB, Tárraga L, Dufouil C, Hardy J, Crane PK, Eiriksdottir G, Hannequin D, Clarke R, Evans D, Mosley TH Jr, Letenneur L, Brayne C, Maier W, De Jager P, Emilsson V, Dartigues JF, Hampel H, Kamboh MI, de Bruijn RF, Tzourio C, Pastor P, Larson EB, Rotter JI, O'Donovan MC, Montine TJ, Nalls MA, Mead S, Reiman EM, Jonsson PV, Holmes C, St George-Hyslop PH, Boada M, Passmore P, Wendland JR, Schmidt R, Morgan K, Winslow AR, Powell JF, Carasquillo M, Younkin SG, Jakobsdóttir J, Kauwe JS, Wilhelmsen KC, Rujescu D, Nöthen MM, Hofman A, Jones L; IGAP Consortium, Haines JL, Psaty BM, Van Broeckhoven C, Holmans P, Launer LJ, Mayeux R, Lathrop M, Goate AM, Escott-Price V, Seshadri S, Pericak-Vance MA, Amouyel P, Williams J, van Duijn CM, Schellenberg GD, Farrer LA.

Mol Psychiatry. 2016 Jan;21(1):108-17. doi: 10.1038/mp.2015.23. Epub 2015 Mar 17.

14.

Small deletion in C9orf72 hides a proportion of expansion carriers in FTLD.

Rollinson S, Bennion Callister J, Young K, Ryan SJ, Druyeh R, Rohrer JD, Snowden J, Richardson A, Jones M, Harris J, Davidson Y, Robinson A, Ealing J, Johnson JO, Traynor B, Mead S, Mann D, Pickering-Brown SM.

Neurobiol Aging. 2015 Mar;36(3):1601.e1-5. doi: 10.1016/j.neurobiolaging.2014.12.009. Epub 2014 Dec 12.

15.

Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.

Gibbons L, Rollinson S, Thompson JC, Robinson A, Davidson YS, Richardson A, Neary D, Pickering-Brown SM, Snowden JS, Mann DM.

Neurobiol Aging. 2015 Mar;36(3):1603.e1-4. doi: 10.1016/j.neurobiolaging.2014.10.023. Epub 2014 Oct 18.

16.

p62/SQSTM1 analysis in frontotemporal lobar degeneration.

Miller L, Rollinson S, Callister JB, Young K, Harris J, Gerhard A, Neary D, Richardson A, Snowden J, Mann DM, Pickering-Brown SM.

Neurobiol Aging. 2015 Mar;36(3):1603.e5-9. doi: 10.1016/j.neurobiolaging.2014.08.035. Epub 2014 Oct 18.

PMID:
25433461
17.

Semantic Corticobasal Dementia: Challenging Nosology in Frontotemporal Lobe Degeneration.

Luzzi S, Fabi K, Cafazzo V, Fringuelli FM, Reverberi C, Baldinelli S, Silvestrini M, Provinciali L, Ascoli G, Pickering-Brown S, Mann D, Neary D, Snowden JS.

Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):360-3. doi: 10.1097/WAD.0000000000000064. No abstract available.

PMID:
25291461
18.

TREM2 analysis and increased risk of Alzheimer's disease.

Finelli D, Rollinson S, Harris J, Jones M, Richardson A, Gerhard A, Snowden J, Mann D, Pickering-Brown S.

Neurobiol Aging. 2015 Jan;36(1):546.e9-13. doi: 10.1016/j.neurobiolaging.2014.08.001. Epub 2014 Aug 27.

PMID:
25260849
19.

Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.

Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DM.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):601-12. doi: 10.1111/nan.12178. Epub 2015 Apr 30.

20.

UBQLN2 variant of unknown significance in frontotemporal lobar degeneration.

Ugwu F, Rollinson S, Harris J, Gerhard A, Richardson A, Jones M, Mann D, Snowden J, Pickering-Brown S.

Neurobiol Aging. 2015 Jan;36(1):546.e15-6. doi: 10.1016/j.neurobiolaging.2014.08.002. Epub 2014 Aug 6.

PMID:
25179229
Items per page

Supplemental Content

Loading ...
Write to the Help Desk